Literature DB >> 16597539

Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium.

Leila I Kump1, René A Cervantes-Castañeda, Sofia N Androudi, C Stephen Foster, William G Christen.   

Abstract

PURPOSE: To determine patterns of exacerbations of recurrent non-infectious uveitis during pregnancy and puerperium.
DESIGN: Retrospective cohort study.
METHODS: The medical records of 32 women with a history of chronic non-infectious uveitis, who were pregnant during their follow-up at the Ocular Immunology and Uveitis Service of the Massachusetts Eye and Ear Infirmary, from 1983 through 2003, were reviewed. The uveitis relapse rate during pregnancy was compared to the relapse rate during pregnancy-free periods in these women and to the relapse rate in a control group of women of childbearing age with recurrent non-infectious uveitis.
RESULTS: Among the 32 women who were pregnant during follow-up (40 pregnancies), the rate of flare-ups during pregnancy (1.0 recurrence per year) was lower than that observed during non-pregnant periods (2.4 per year; p<0.001) and lower than that observed in the non-pregnant control group (3.1 per year; p<0.001). Flare-ups were most frequent in the first trimester of pregnancy and decreased markedly in the second and third trimesters (2.3, 0.5, and 0.4 recurrences per year, respectively; p<0.001).
CONCLUSIONS: Pregnancy is associated with lower numbers of flare-ups of non-infectious uveitis compared to the non-pregnant state. If flare-ups do occur during pregnancy, they happen predominantly in the first trimester.

Entities:  

Mesh:

Year:  2006        PMID: 16597539     DOI: 10.1080/09273940500557027

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  12 in total

Review 1.  [Management of patients with ocular diseases during pregnancy. Diabetes, glaucoma and uveitis].

Authors:  F Mackensen; R Max
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

Review 2.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

Review 3.  Ocular changes during pregnancy.

Authors:  Friederike Mackensen; Wolfgang E Paulus; Regina Max; Thomas Ness
Journal:  Dtsch Arztebl Int       Date:  2014-08-18       Impact factor: 5.594

4.  Recurrence rates of ocular toxoplasmosis during pregnancy.

Authors:  Arthur M D Braakenburg; Catherine M Crespi; Gary N Holland; Sheng Wu; Fei Yu; Aniki Rothova
Journal:  Am J Ophthalmol       Date:  2014-01-09       Impact factor: 5.258

5.  The effect of pregnancy on the course of uveitis in single and multiple pregnancies.

Authors:  Yael Sharon; Avital Adler; Alon Tiosano; Juan M Sanchez; Radgonde Amer; Michal Kramer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-12       Impact factor: 3.535

6.  Idiopathic multifocal choroiditis and punctate inner choroidopathy: an evaluation in pregnancy.

Authors:  Evianne L de Groot; Ramon A C van Huet; Kitty W M Bloemenkamp; Joke H de Boer; Jeannette Ossewaarde-van Norel
Journal:  Acta Ophthalmol       Date:  2021-05-19       Impact factor: 3.988

Review 7.  Uveitis and gender: the course of uveitis in pregnancy.

Authors:  Nathalie P Y Chiam; Lyndell L P Lim
Journal:  J Ophthalmol       Date:  2014-01-09       Impact factor: 1.909

Review 8.  Enhanced Depth Imaging Optical Coherence Tomography: A New Way Measuring Choroidal Thickness in Pregnant Women.

Authors:  Jun Zhang; Huiyun Wang; Qiubo Yu; Qihu Tong; Qinkang Lu
Journal:  J Ophthalmol       Date:  2017-05-25       Impact factor: 1.909

Review 9.  The eye and visual system in pregnancy, what to expect? An in-depth review.

Authors:  Khawla Abu Samra
Journal:  Oman J Ophthalmol       Date:  2013-05

Review 10.  Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia.

Authors:  Yujuan Wang; Chi-Chao Chan
Journal:  J Ophthalmol       Date:  2014-03-05       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.